FDA.reportPublic FDA data

Voyxact 400 MG in 2 ML Prefilled Syringe

RxCUI
2728407
RxNorm name
Voyxact 400 MG in 2 ML Prefilled Syringe
Display name
Voyxact 400 MG in 2 ML Prefilled Syringe
Full name
Voyxact 400 MG in 2 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761434Voyxactsibeprenlimab-szsi351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
c8a93b32-0676-4704-86dc-cb65f425c6e5Voyxact 400 MG in 2 ML Prefilled SyringePSN3These highlights do not include all the information needed to use VOYXACT safely and effectively. See full prescribing information for VOYXACT. VOYXACT ® (sibeprenlimab-szsi) injection, for subcutaneous use Initial U.S. Approval: 202520260317
c8a93b32-0676-4704-86dc-cb65f425c6e52 ML sibeprenlimab-szsi 200 MG/ML Prefilled Syringe [Voyxact]SBD3These highlights do not include all the information needed to use VOYXACT safely and effectively. See full prescribing information for VOYXACT. VOYXACT ® (sibeprenlimab-szsi) injection, for subcutaneous use Initial U.S. Approval: 202520260317
c8a93b32-0676-4704-86dc-cb65f425c6e5Voyxact 400 MG per 2 ML Prefilled SyringeSY3These highlights do not include all the information needed to use VOYXACT safely and effectively. See full prescribing information for VOYXACT. VOYXACT ® (sibeprenlimab-szsi) injection, for subcutaneous use Initial U.S. Approval: 202520260317